ESTRO-EANO

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

ESTRO posted on LinkedIn:

ESTRO-EANO guideline on target delineation and radiotherapy for IDH mutant WHO CNS grade 2 and 3 diffuse glioma, just published in the Green Journal.”

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma